Advertisement

Hormones

, Volume 18, Issue 1, pp 23–35 | Cite as

Vitamin D and health in the Mediterranean countries

  • William B. GrantEmail author
Review Article

Abstract

Vitamin D, traditionally well known for its role in maintaining optimal health through its contribution to calcium metabolism and skeletal health, has received increased attention over the past two decades, with considerable focus being placed on its nonskeletal benefits. This paper is a narrative review of the nonskeletal health benefits of vitamin D, of particular interest to inhabitants of Mediterranean countries, namely, autism, cancer, cardiovascular disease, chronic obstructive pulmonary disease, dental caries, diabetes mellitus, erectile dysfunction, hypertension, metabolic syndrome, respiratory tract infections, all-cause mortality, and pregnancy and birth outcomes, because of the relatively high incidence and/or prevalence of these disorders in this region. Currently, the best evidence is coming out of observational studies related to serum 25-hydroxyvitamin D [25(OH)D] concentrations. Vitamin D clinical trials have generally been poorly designed and conducted, usually being based on vitamin D dose rather than 25(OH)D concentration. The optimal 25(OH)D concentration is above 75 nmol/l (30 ng/ml), with even better health outcomes in the range of 100–150 nmol/l. Achieving these concentrations with vitamin D3 supplements will require 1000–4000 IU/day of vitamin D3. Sensible sun exposure should also be encouraged. Countries should also consider fortifying grain and dairy products with vitamin D3.

Keywords

Vitamin D Autism Cancer Cardiovascular disease Dental caries Respiratory tract infections All-cause mortality Pregnancy and birth outcomes 

Notes

Compliance with ethical standards

Conflict of interest

The author receives funding from Bio-Tech Pharmacal (Fayetteville, AR).

References

  1. 1.
    Grant WB (2016) The role of geographical ecological studies in identifying diseases linked to UVB exposure and/or vitamin D. Dermatoendocrinol 8:e1137400Google Scholar
  2. 2.
    Theodoratou E, Tzoulaki I, Zgaga L, Ioannidis JP (2014) Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials. BMJ 348:g2035Google Scholar
  3. 3.
    Veldurthy V, Wei R, Campbell M et al (2016) 25-Hydroxyvitamin D3 24-hydroxylase: a key regulator of 1,25(OH)2D3 catabolism and calcium homeostasis. Vitam Horm 100:137–150Google Scholar
  4. 4.
    Rejnmark L, Bislev LS, Cashman KD et al (2017) Non-skeletal health effects of vitamin D supplementation: a systematic review on findings from meta-analyses summarizing trial data. PLoS One 12:e0180512Google Scholar
  5. 5.
    Bhattoa HP, Konstantynowicz J, Laszcz N et al (2017) Vitamin D: musculoskeletal health. Rev Endocr Metab Disord 18:363–371Google Scholar
  6. 6.
    Holick MF (2007) Vitamin D deficiency. N Engl J Med 357:266–281Google Scholar
  7. 7.
    Autier P, Boniol M, Pizot C, Mullie P (2014) Vitamin D status and ill health: a systematic review. Lancet Diabetes Endocrinol 2:76–89Google Scholar
  8. 8.
    Pludowski P, Holick MF, Pilz S et al (2013) Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-a review of recent evidence. Autoimmun Rev 12:976–989Google Scholar
  9. 9.
    Bikle DD (2016) Extraskeletal actions of vitamin D. Ann N Y Acad Sci 1376:29–52Google Scholar
  10. 10.
    Autier P, Mullie P, Macacu A et al (2017) Effect of vitamin D supplementation on non-skeletal disorders: a systematic review of meta-analyses and randomised trials. Lancet Diabetes Endocrinol 5:986–1004Google Scholar
  11. 11.
    Pike JW, Meyer MB, Benkusky NA et al (2016) Genomic determinants of vitamin D-regulated gene expression. Vitam Horm 100:21–44Google Scholar
  12. 12.
    Hossein-Nezhad A, Mirzaei K et al (2013) Evidences of dual role of vitamin D through cellular energy homeostasis and inflammation pathway in risk of cancer in obese subjects. Minerva Med 104:295–307Google Scholar
  13. 13.
    Zehnder D, Bland R, Williams MC et al (2001) Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase. J Clin Endocrinol Metab 86:888–894Google Scholar
  14. 14.
    Jablonski NG, Chaplin G (2000) The evolution of human skin coloration. J Hum Evol 39:57–106Google Scholar
  15. 15.
    Jablonski NG, Chaplin G (2010) Colloquium paper: human skin pigmentation as an adaptation to UV radiation. Proc Natl Acad Sci U S A 107(Suppl 2):8962–8968Google Scholar
  16. 16.
    Grant WB (2016) The UVB-vitamin D3 -pigment hypothesis is alive and well. Am J Phys Anthropol 161:752–755Google Scholar
  17. 17.
    Grant WB (2002) An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet-B radiation. Cancer 94:1867–1875Google Scholar
  18. 18.
    Grant WB, Garland CF (2006) The association of solar ultraviolet B (UVB) with reducing risk of cancer: multifactorial ecologic analysis of geographic variation in age-adjusted cancer mortality rates. Anticancer Res 26:2687–2699Google Scholar
  19. 19.
    Moukayed M, Grant WB (2013) Molecular link between vitamin D and cancer prevention. Nutrients 5:3993–4021Google Scholar
  20. 20.
    Grant WB (2010) An ecological study of cancer incidence and mortality rates in France with respect to latitude, an index for vitamin D production. Dermatoendocrinol 2:62–67Google Scholar
  21. 21.
    Grant WB (2007) An ecologic study of cancer mortality rates in Spain with respect to indices of solar UVB irradiance and smoking. Int J Cancer 120:1123–1128Google Scholar
  22. 22.
    Grant WB (2015) 25-Hydroxyvitamin D and breast cancer, colorectal cancer, and colorectal adenomas: case-control versus nested case-control studies. Anticancer Res 35:1153–1160Google Scholar
  23. 23.
    Grant WB, Boucher BJ (2017) Randomized controlled trials of vitamin D and cancer incidence: a modeling study. PLoS One 12:e0176448Google Scholar
  24. 24.
    Jenab M, Bueno-de-Mesquita HB et al (2010) Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations:a nested case-control study. BMJ 340:b5500Google Scholar
  25. 25.
    Fedirko V, Duarte-Salles T, Bamia C et al (2014) Prediagnostic circulating vitamin D levels and risk of hepatocellular carcinoma in European populations: a nested case-control study. Hepatology 60:1222–1230Google Scholar
  26. 26.
    Muller DC, Fanidi A, Midttun O et al (2014) Circulating 25-hydroxyvitamin D3 in relation to renal cell carcinoma incidence and survival in the EPIC cohort. Am J Epidemiol 180:810–820Google Scholar
  27. 27.
    Kuhn T, Kaaks R, Becker S et al (2013) Plasma 25-hydroxyvitamin D and the risk of breast cancer in the European prospective investigation into cancer and nutrition: a nested case-control study. Int J Cancer 133:1689–1700Google Scholar
  28. 28.
    van Duijnhoven FJB, Jenab M, Hveem K et al (2018) Circulating concentrations of vitamin D in relation to pancreatic cancer risk in European populations. Int J Cancer 142:1189–1201Google Scholar
  29. 29.
    Engel P, Fagherazzi G, Mesrine S et al (2011) Joint effects of dietary vitamin D and sun exposure on breast cancer risk: results from the French E3N cohort. Cancer Epidemiol Biomark Prev 20:187–198Google Scholar
  30. 30.
    Lope V, Castello A, Mena-Bravo A et al (2018) Serum 25-hydroxyvitamin and breast cancer risk by pathological subtype (MCC-Spain). J Steroid Biochem Mol Biol 182:4–13Google Scholar
  31. 31.
    Tretli S, Schwartz GG, Torjesen PA, Robsahm TE (2012) Serum levels of 25-hydroxyvitamin D and survival in Norwegian patients with cancer of breast, colon, lung, and lymphoma: a population-based study. Cancer Causes Control 23:363–370Google Scholar
  32. 32.
    Fedirko V, Torres-Mejia G, Ortega-Olvera C et al (2012) Serum 25-hydroxyvitamin D and risk of breast cancer: results of a large population-based case-control study in Mexican women. Cancer Causes Control 23:1149–1162Google Scholar
  33. 33.
    Mohr SB, Gorham ED, Kim J, Hofflich H, Cuomo RE, Garland CF (2015) Could vitamin D sufficiency improve the survival of colorectal cancer patients? J Steroid Biochem Mol Biol 148:239–244Google Scholar
  34. 34.
    Fanidi A, Muller DC, Midttun O et al (2016) Circulating vitamin D in relation to cancer incidence and survival of the head and neck and oesophagus in the EPIC cohort. Sci Rep 6:36017Google Scholar
  35. 35.
    Webb PM, de Fazio A, Protani MM et al (2015) Circulating 25-hydroxyvitamin D and survival in women with ovarian cancer. Am J Clin Nutr 102:109–114Google Scholar
  36. 36.
    Zhang X, Huang X-Z, Chen W-J et al 2017 Plasma 25-hydroxyvitamin D levels, vitamin D intake, and pancreatic risk or mortality: a meta-analysis. Oncotarget 8(38):64395–64406Google Scholar
  37. 37.
    Meyer HE, Stoer NC, Samuelsen SO et al (2016) Long term association between serum 25-Hydroxyvitamin D and mortality in a cohort of 4379 men. PLoS One 11:e0151441Google Scholar
  38. 38.
    Moukayed M, Grant WB (2017) The roles of UVB and vitamin D in reducing risk of cancer incidence and mortality: a review of the epidemiology, clinical trials, and mechanisms. Rev Endocr Metab Disord 5(10):3993–4021Google Scholar
  39. 39.
    Lappe JM, Travers-Gustafson D, Davies KM et al (2007) Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 85:1586–1591Google Scholar
  40. 40.
    Bolland MJ, Grey A, Gamble GD, Reid IR (2011) Calcium and vitamin D supplements and health outcomes: a reanalysis of the Women’s Health Initiative (WHI) limited-access data set. Am J Clin Nutr 94:1144–1149Google Scholar
  41. 41.
    Lappe J, Watson P, Travers-Gustafson D et al (2017) Effect of vitamin D and calcium supplementation on Cancer incidence in older women: a randomized clinical trial. JAMA 317:1234–1243Google Scholar
  42. 42.
    Amaral AF, Mendez-Pertuz M, Munoz A et al (2012) Plasma 25-hydroxyvitamin D(3) and bladder cancer risk according to tumor stage and FGFR3 status: a mechanism-based epidemiological study. J Natl Cancer Inst 104:1897–1904Google Scholar
  43. 43.
    Ben Fradj MK, Gargouri MM, Hammami MB et al (2016) Bladder Cancer is associated with low plasma 25-hydroxyvitamin D concentrations in Tunisian population. Nutr Cancer 68:208–213Google Scholar
  44. 44.
    Afzal S, Bojesen SE, Nordestgaard BG (2013) Low plasma 25-hydroxyvitamin D and risk of tobacco-related cancer. Clin Chem 59:771–780Google Scholar
  45. 45.
    Alberti KG, Eckel RH, Grundy SM et al (2009) Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; National Heart, Lung, and Blood Institute; American Heart Association; world heart federation; international atherosclerosis society; and International Association for the Study of obesity. Circulation 120:1640–1645Google Scholar
  46. 46.
    Al-Daghri NM, Alkharfy KM, Al-Saleh Y et al (2012) Modest reversal of metabolic syndrome manifestations with vitamin D status correction: a 12-month prospective study. Metab Clin Exp 61:661–666Google Scholar
  47. 47.
    Pham TM, Ekwaru JP, Setayeshgar S, Veugelers PJ (2015) The effect of changing serum 25-Hydroxyvitamin D concentrations on metabolic syndrome: a longitudinal analysis of participants of a preventive health program. Nutrients 7:7271–7284Google Scholar
  48. 48.
    Sluyter JD, Camargo CA, Jr., Stewart AW et al (2017) Effect of monthly, high-dose, long-term vitamin D supplementation on central blood pressure parameters: a randomized controlled trial substudy. J Am Heart Assoc 6(10)Google Scholar
  49. 49.
    Mirhosseini N, Vatanparast H, Kimball SM (2017) The association between serum 25(OH)D status and blood pressure in participants of a community-based program taking vitamin D supplements. Nutrients 9(11)Google Scholar
  50. 50.
    Douglas AS, al-Sayer H, Rawles JM, Allan TM (1991) Seasonality of disease in Kuwait. Lancet 337:1393–1397Google Scholar
  51. 51.
    Zhang R, Li B, Gao X, Tian R et al (2017) Serum 25-hydroxyvitamin D and the risk of cardiovascular disease: dose-response meta-analysis of prospective studies. Am J Clin Nutr 105:810–819Google Scholar
  52. 52.
    Veloudi P, Jones G, Sharman JE (2017) Effectiveness of vitamin D supplementation for cardiovascular health outcomes. Pulse (Basel) 4:193–207Google Scholar
  53. 53.
    Greco D, Kocyigit D, Adorni MP et al (2018) Vitamin D replacement ameliorates serum lipoprotein functions, adipokine profile and subclinical atherosclerosis in pre-menopausal women. Nutr Metab Cardiovasc Dis  https://doi.org/10.1016/j.numecd.2018.04.010
  54. 54.
    Cinar N, Harmanci A, Yildiz BO, Bayraktar M (2014) Vitamin D status and seasonal changes in plasma concentrations of 25-hydroxyvitamin D in office workers in Ankara, Turkey. Eur J Intern Med 25:197–201Google Scholar
  55. 55.
    Gouveri E, Papanas N, Hatzitolios AI, Maltezos E (2012) Hypovitaminosis D and peripheral arterial disease: emerging link beyond cardiovascular risk factors. Eur J Intern Med 23:674–681Google Scholar
  56. 56.
    Iannuzzo G, Forte F, Lupoli R, Di Minno MND (2018) Association of Vitamin D deficiency with peripheral arterial disease: a meta-analysis of literature studies. J Clin Endocrinol Metab  https://doi.org/10.1210/jc.2018-00136
  57. 57.
    Sorenson M, Grant WB (2012) Does vitamin D deficiency contribute to erectile dysfunction? Dermatoendocrinol 4:128–136Google Scholar
  58. 58.
    Barassi A, Pezzilli R, Colpi GM et al (2014) Vitamin D and erectile dysfunction. J Sex Med 11:2792–2800Google Scholar
  59. 59.
    Caretta N, de Kreutzenberg SV, Valente U et al (2016) Hypovitaminosis D is associated with erectile dysfunction in type 2 diabetes. Endocrine 53:831–838Google Scholar
  60. 60.
    Basat S, Sivritepe R, Ortaboz D et al (2018) The relationship between vitamin D level and erectile dysfunction in patients with type 2 diabetes mellitus. Aging Male 21:111–115Google Scholar
  61. 61.
    Ekmekcioglu C, Haluza D, Kundi M (2017) 25-Hydroxyvitamin D status and risk for colorectal cancer and type 2 diabetesmellitus: a systematic review and meta-analysis of epidemiological studies. Int J Environ Res Public Health 14(2)Google Scholar
  62. 62.
    Lucato P, Solmi M, Maggi S et al (2017) Low vitamin D levels increase the risk of type 2 diabetes in older adults: a systematic review and meta-analysis. Maturitas 100:8–15Google Scholar
  63. 63.
    Park SK, Garland CF, Gorham ED et al (2018) Plasma 25-hydroxyvitamin D concentration and risk of type 2 diabetes and pre-diabetes: 12-year cohort study. PLoS One 13:e0193070Google Scholar
  64. 64.
    Wu C, Qiu S, Zhu X, Li L (2017) Vitamin D supplementation and glycemic control in type 2 diabetes patients: a systematic review and meta-analysis. Metab Clin Exp 73:67–76Google Scholar
  65. 65.
    Karras SN, Anagnostis P, Antonopoulou V et al (2018) The combined effect of vitamin D and parathyroid hormone concentrations on glucose homeostasis in older patients with prediabetes: a cross-sectional study. Diab Vasc Dis Res 15:150–153Google Scholar
  66. 66.
    Hypponen E, Laara E, Reunanen A et al (2001) Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 358:1500–1503Google Scholar
  67. 67.
    Hypponen E (2010) Vitamin D and increasing incidence of type 1 diabetes-evidence for an association? Diabetes Obes Metab 12:737–743Google Scholar
  68. 68.
    Munger KL, Levin LI, Massa J et al (2013) Preclinical serum 25-hydroxyvitamin D levels and risk of type 1 diabetes in a cohort of US military personnel. Am J Epidemiol 177:411–419Google Scholar
  69. 69.
    Piazzolla G, Castrovilli A, Liotino V et al (2017) Metabolic syndrome and Chronic Obstructive Pulmonary Disease (COPD): the interplay among smoking, insulin resistance and vitamin D. PLoS One 12:e0186708Google Scholar
  70. 70.
    Cannell JJ, Vieth R, Umhau JC et al (2006) Epidemic influenza and vitamin D. Epidemiol Infect 134:1129–1140Google Scholar
  71. 71.
    Aloia JF, Li-Ng M (2007) Re: epidemic influenza and vitamin D. Epidemiol Infect 135:1095–1096 author reply 1097–1098Google Scholar
  72. 72.
    Urashima M, Segawa T, Okazaki M et al (2010) Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am J Clin Nutr 91:1255–1260Google Scholar
  73. 73.
    Martineau AR, Jolliffe DA, Hooper RL et al (2017) Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ 356:i6583Google Scholar
  74. 74.
    Liu PT, Stenger S, Li H et al (2006) Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311:1770–1773Google Scholar
  75. 75.
    Borella E, Nesher G, Israeli E, Shoenfeld Y (2014) Vitamin D: a new anti-infective agent? Ann N Y Acad Sci 1317:76–83Google Scholar
  76. 76.
    Grant WB (2011) An estimate of the global reduction in mortality rates through doubling vitamin D levels. Eur J Clin Nutr 65:1016–1026Google Scholar
  77. 77.
    Grant WB, Whiting SJ, Schwalfenberg GK et al (2016) Estimated economic benefit of increasing 25-hydroxyvitamin D concentrations of Canadians to or above 100 nmol/L. Dermatoendocrinol 8:e1248324Google Scholar
  78. 78.
    Garland CF, Kim JJ, Mohr SB et al (2014) Meta-analysis of all-cause mortality according to serum 25-hydroxyvitamin D. Am J Public Health 104:e43–e50Google Scholar
  79. 79.
    Lindqvist PG, Epstein E, Nielsen K et al (2016) Avoidance of sun exposure as a risk factor for major causes of death: a competing risk analysis of theMelanoma in Southern Sweden cohort. J Intern Med 280(4):375–87Google Scholar
  80. 80.
    Engelsen O (2010) The relationship between ultraviolet radiation exposure and vitamin D status. Nutrients 2:482–495Google Scholar
  81. 81.
    Gaksch M, Jorde R, Grimnes G et al (2017) Vitamin D and mortality: individual participant data meta-analysis of standardized 25-hydroxyvitamin D in 26916 individuals from a European consortium. PLoS One 12:e0170791Google Scholar
  82. 82.
    Karras SN, Fakhoury H, Muscogiuri G et al (2016) Maternal vitamin D levels during pregnancy and neonatal health: evidence to date and clinical implications. Ther Adv Musculoskelet Dis 8:124–135Google Scholar
  83. 83.
    Merewood A, Mehta SD, Chen TC et al (2009) Association between vitamin D deficiency and primary cesarean section. J Clin Endocrinol Metab 94:940–945Google Scholar
  84. 84.
    McDonnell SL, Baggerly KA, Baggerly CA et al (2017) Maternal 25(OH)D concentrations >/=40 ng/mL associated with 60% lower preterm birth risk among general obstetrical patients at an urban medical center. PLoS One 12:e0180483Google Scholar
  85. 85.
    Triunfo S, Lanzone A, Lindqvist PG (2017) Low maternal circulating levels of vitamin D as potential determinant in the development of gestational diabetes mellitus. J Endocrinol Investig 40:1049–1059Google Scholar
  86. 86.
    Mirzakhani H, Litonjua AA, McElrath TF et al (2016) Early pregnancy vitamin D status and risk of preeclampsia. J Clin Invest 126:4702–4715Google Scholar
  87. 87.
    Weinert LS, Reichelt AJ, Schmitt LR et al (2016) Vitamin D deficiency increases the risk of adverse neonatal outcomes in gestational diabetes. PLoS One 11:e0164999Google Scholar
  88. 88.
    Hollis BW, Johnson D, Hulsey TC et al (2011) Vitamin D supplementation during pregnancy: double-blind, randomized clinical trial of safety and effectiveness. J Bone Miner Res 26:2341–2357Google Scholar
  89. 89.
    Wagner CL, Hollis BW, Kotsa K et al (2017) Vitamin D administration during pregnancy as prevention for pregnancy, neonatal and postnatal complications. Rev Endocr Metab Disord 18:307–322Google Scholar
  90. 90.
    Karras SN, Wagner CL, Castracane VD (2017) Understanding vitamin D metabolism in pregnancy: from physiology to pathophysiology and clinical outcomes. Metab Clin Exp 86:112–123Google Scholar
  91. 91.
    Daraki V, Roumeliotaki T, Koutra K et al (2018) High maternal vitamin D levels in early pregnancy may protect against behavioral difficulties at preschool age: the Rhea mother-child cohort, Crete, Greece. Eur Child Adolesc Psychiatry 27:79–88Google Scholar
  92. 92.
    Cannell JJ (2008) Autism and vitamin D. Med Hypotheses 70:750–759Google Scholar
  93. 93.
    Grant WB, Cannell JJ (2013) Autism prevalence in the United States with respect to solar UV-B doses: an ecological study. Dermatoendocrinol 5:159–164Google Scholar
  94. 94.
    Patrick RP, Ames BN (2014) Vitamin D hormone regulates serotonin synthesis. Part 1: relevance for autism. FASEB J 28:2398–2413Google Scholar
  95. 95.
    Meguid NA, Hashish AF, Anwar M, Sidhom G (2010) Reduced serum levels of 25-hydroxy and 1,25-dihydroxy vitamin D in Egyptian children with autism. J Altern Complement Med 16:641–645Google Scholar
  96. 96.
    Saad K, Abdel-Rahman AA, Elserogy YM et al (2018) Randomized controlled trial of vitamin D supplementation in children with autism spectrum disorder. J Child Psychol Psychiatry Allied Discip 59:20–29Google Scholar
  97. 97.
    Grant WB (2011) A review of the role of solar ultraviolet-B irradiance and vitamin D in reducing risk of dental caries. Dermatoendocrinol 3:193–198Google Scholar
  98. 98.
    Hujoel PP (2013) Vitamin D and dental caries in controlled clinical trials: systematic review and meta-analysis. Nutr Rev 71:88–97Google Scholar
  99. 99.
    Schroth RJ, Lavelle C, Tate R et al (2014) Prenatal vitamin D and dental caries in infants. Pediatrics 133:e1277–e1284Google Scholar
  100. 100.
    Schroth RJ, Rabbani R, Loewen G, Moffatt ME (2016) Vitamin D and dental caries in children. J Dent Res 95:173–179Google Scholar
  101. 101.
    Grant WB, Boucher BJ (2010) Are Hill’s criteria for causality satisfied for vitamin D and periodontal disease? Dermatoendocrinol 2:30–36Google Scholar
  102. 102.
    Martelli FS, Martelli M, Rosati C, Fanti E (2014) Vitamin D: relevance in dental practice. Clin Cases Miner Bone Metab 11:15–19Google Scholar
  103. 103.
    Laky M, Bertl K, Haririan H et al (2017) Serum levels of 25-hydroxyvitamin D are associated with periodontal disease. Clin Oral Investig 21:1553–1558Google Scholar
  104. 104.
    Karras SN, Anagnostis P, Petroczi A et al (2015) Maternal vitamin D status in pregnancy: a critical appraisal of current analytical data on maternal and neonatal outcomes. Hormones (Athens) 14:224–231Google Scholar
  105. 105.
    Garland CF, French CB, Baggerly LL, Heaney RP (2011) Vitamin D supplement doses and serum 25-hydroxyvitamin D in the range associated with cancer prevention. Anticancer Res 31:607–611Google Scholar
  106. 106.
    Karras SN, Anagnostis P, Naughton D et al (2015) Vitamin D during pregnancy: why observational studies suggest deficiency and interventional studies show no improvement in clinical outcomes? A narrative review. J Endocrinol Investig 38:1265–1275Google Scholar
  107. 107.
    Grant WB, Boucher BJ, Bhattoa HP, Lahore H (2018) Why vitamin D clinical trials should be based on 25-hydroxyvitamin D concentrations. J Steroid Biochem Mol Biol 177:266-269Google Scholar
  108. 108.
    Wagner CL, McNeil RB, Johnson DD et al (2013) Health characteristics and outcomes of two randomized vitamin D supplementation trials during pregnancy: a combined analysis. J Steroid Biochem Mol Biol 136:313–320Google Scholar
  109. 109.
    Oussedik-Lehtihet S, Haouichat C, Hammoumraoui N et al (2017) Hypovitaminosis D and its associated factors in North Algerian postmenopausal women: results of a cross-sectional study. J Nutr Metab 2017:9032141Google Scholar
  110. 110.
    Sokolovic S, Alimanovic-Alagic R, Dzananovic L et al (2017) Vitamin D status in Bosnia and Herzegovina: the cross-sectional epidemiological analysis. Osteoporos Int 28:1021–1025Google Scholar
  111. 111.
    Keser I, Cvijetic S, Bituh M et al (2018) Vitamin D and parathyroid hormone in relation to bone health in Croatian women. Arch Osteoporos 13:69Google Scholar
  112. 112.
    Manios Y,Moschonis G, Lambrinou CP et al (2017) A systematic review of vitamin D status in southern European countries. Eur J Nutr 57(6):2001–2036Google Scholar
  113. 113.
    El Maataoui A, Biaz A, El Machtani S et al (2016) Vitamin D status in healthy Moroccan men and women aged 50 years and older: a cross-sectional study. Arch Osteoporos 11:24Google Scholar
  114. 114.
    Solak I, Cihan FG, Mercan S et al (2018) Evaluation of 25-hydroxyvitamin D levels in Central Anatolia, Turkey. Biomed Res Int 2018:4076548Google Scholar
  115. 115.
    Hilger J, Friedel A, Herr R et al (2014) A systematic review of vitamin D status in populations worldwide. Br J Nutr 111:23–45Google Scholar
  116. 116.
    Crowe FL, Steur M, Allen NE et al (2011) Plasma concentrations of 25-hydroxyvitamin D in meat eaters, fish eaters, vegetarians and vegans: results from the EPIC-Oxford study. Public Health Nutr 14:340–346Google Scholar
  117. 117.
    FAO Food balance sheets. In: Food and Agriculture Organizaiton of the United Nations. http://www.fao.org/faostat/en/#data/FBS
  118. 118.
    MacLaughlin J, Holick MF (1985) Aging decreases the capacity of human skin to produce vitamin D3. J Clin Invest 76:1536–1538Google Scholar
  119. 119.
    Karras S, Paschou SA, Kandaraki E et al (2016) Hypovitaminosis D in pregnancy in the Mediterranean region: a systematic review. Eur J Clin Nutr 70:979–986Google Scholar
  120. 120.
    Sorenson MB, Grant WB (2018) Embrace the sun. Marc B. Sorenson, United StatesGoogle Scholar
  121. 121.
    Ross AC, Manson JE, Abrams SA et al (2011) The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 96:53–58Google Scholar
  122. 122.
    Holick MF, Binkley NC, Bischoff-Ferrari HA et al (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96:1911–1930Google Scholar
  123. 123.
    Pludowski P, Holick MF, Grant WB et al (2018) Vitamin D supplementation guidelines. J Steroid Biochem Mol Biol 175:125–135Google Scholar
  124. 124.
    McDonnell SL, Baggerly CA, French CB et al (2018) Breast cancer risk markedly lower with serum 25-hydroxyvitamin D concentrations >/=60 vs <20 ng/ml (150 vs 50 nmol/L): pooled analysis of two randomized trials and a prospective cohort. PLoS One 13:e0199265Google Scholar
  125. 125.
    Grant WB, Karras SN, Bischoff-Ferrari HA et al (2016) Do studies reporting ‘U’-shaped serum 25-hydroxyvitamin D-health outcome relationships reflect adverse effects? Dermatoendocrinol 8:e1187349Google Scholar
  126. 126.
    Cannell JJ, Hollis BW, Sorenson MB et al (2009) Athletic performance and vitamin D. Med Sci Sports Exerc 41:1102–1110Google Scholar
  127. 127.
    Rooney MR, Harnack L, Michos ED et al (2017) Trends in use of high-dose vitamin D supplements exceeding 1000 or 4000 international units daily, 1999-2014. JAMA 317:2448–2450Google Scholar
  128. 128.
    Gronborg IM, Tetens I, Ege M et al (2018) Modelling of adequate and safe vitamin D intake in Danish women using different forti fication and supplementation scenarios to inform fortification policies. Eur J Nutr  https://doi.org/10.1007/s00394-017-1586-9
  129. 129.
    O'Neill CM, Kazantzidis A, Kiely M et al (2017) A predictive model of serum 25-hydroxyvitamin D in UK white as well as black and Asian minority ethnic population groups for application in food fortification strategy development towards vitamin D deficiency prevention. J Steroid Biochem Mol Biol 173:245–252Google Scholar
  130. 130.
    Allen RE, Dangour AD, Tedstone AE, Chalabi Z (2015) Does fortification of staple foods improve vitamin D intakes and status of groups at risk of deficiency? A United Kingdom modeling study. Am J Clin Nutr 102:338–344Google Scholar
  131. 131.
    Nikooyeh B, Neyestani TR, Zahedirad M et al (2016) Vitamin D-fortified bread is as effective as supplement in improving vitamin D status: a randomized clinical trial. J Clin Endocrinol Metab 101:2511–2519Google Scholar
  132. 132.
    Pilz S, Marz W, Cashman KD, et al 2018 Rationale and plan for vitamin D food fortification; a review and guidance paper. Front Endocrinol (Lausanne). 9:373Google Scholar
  133. 133.
    Naugler C, Hemmelgarn B, Quan H et al (2017) Implementation of an intervention to reduce population-based screening for vitamin D deficiency: a cross-sectional study. CMAJ Open 5:E36–E39Google Scholar
  134. 134.
    Annweiler C, Kabeshova A, Callens A et al (2017) Self-administered Vitamin D Status Predictor: older adults are able to use a self-questionnaire for evaluating their vitamin D status. PLoS One 12:e0186578Google Scholar

Copyright information

© Hellenic Endocrine Society 2018

Authors and Affiliations

  1. 1.Sunlight, Nutrition, and Health Research CenterSan FranciscoUSA

Personalised recommendations